FEMY$1.323.65%-0.05
Femasys Inc (FEMY)
Date: 2026-11-02 16:00O: 1.37H: 1.42L: 1.29C: 1.32Vol: 129.9k
Femasys Inc stock is traded at $1.32, with a volume of 129,859. It is down -3.65% in the last 24 hours and down -35.61% over the past month. Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.
Previous Close:
$1.37
Open:
$1.37
24h Volume:
129,859
Relative Volume:
1.18
Market Cap:
$11.06M
Revenue:
$2.38M
Net Income/Loss:
-$12.40M
P/E Ratio:
-
EPS:
-$6.46
Net Cash Flow:
-$18.68M
1W Performance:
-3.65%
1M Performance:
-35.61%
6M Performance:
-82.81%
1Y Performance:
-89.96%
1-Day Range:
$0.00$0.00
1-Week Range:
$1.29$1.44
52-Week Range:
$1.29$22.20
Femasys Inc Stock (FEMY) Company Profile
Name
Femasys IncSector
HealthcareIndustry
Medical Instruments & SuppliesPhone
770-500-3910Address
3950 JOHNS CREEK COURT, SUWANEE, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS
Femasys Inc Stock (FEMY) Upgrades & Downgrades
Femasys Inc Stock (FEMY) Financials Data
Femasys Inc Stock (FEMY) Insider Trading
- Mifek Jeffrey GeraldAug 07 '26Chief Clinical-Medical Affairs
- Transaction
- Buy
- Cost
- $3.20
- #Shares
- 3,125
- Value ($)
- 10,000
- #Shares Total
- 3,125
- Sipos Jeremy AlexanderAug 07 '26Chief Technology Officer
- Transaction
- Buy
- Cost
- $3.20
- #Shares
- 3,125
- Value ($)
- 10,000
- #Shares Total
- 3,125
- Canning John CharlesAug 07 '26Chief Operating Officer
- Transaction
- Buy
- Cost
- $3.20
- #Shares
- 4,375
- Value ($)
- 14,000
- #Shares Total
- 4,375
- Elefant DovAug 07 '26Chief Financial Officer
- Transaction
- Buy
- Cost
- $3.20
- #Shares
- 15,625
- Value ($)
- 50,000
- #Shares Total
- 15,625
- Lee-Sepsick KathyAug 07 '26Chief Executive Officer
- Transaction
- Buy
- Cost
- $3.20
- #Shares
- 15,625
- Value ($)
- 50,000
- #Shares Total
- 15,625
